DE69907926D1 - 1,2,4-triazol-3-thion verbindungen - Google Patents

1,2,4-triazol-3-thion verbindungen

Info

Publication number
DE69907926D1
DE69907926D1 DE69907926T DE69907926T DE69907926D1 DE 69907926 D1 DE69907926 D1 DE 69907926D1 DE 69907926 T DE69907926 T DE 69907926T DE 69907926 T DE69907926 T DE 69907926T DE 69907926 D1 DE69907926 D1 DE 69907926D1
Authority
DE
Germany
Prior art keywords
triazol
thion compounds
compounds
thion
triazole
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69907926T
Other languages
English (en)
Other versions
DE69907926T2 (de
Inventor
Andrew Baxter
Colin Bennion
Peter Cage
Nicholas Kindon
Michael Mortimore
Bryan Roberts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Application granted granted Critical
Publication of DE69907926D1 publication Critical patent/DE69907926D1/de
Publication of DE69907926T2 publication Critical patent/DE69907926T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
DE69907926T 1998-09-01 1999-08-27 1,2,4-triazol-3-thion verbindungen Expired - Fee Related DE69907926T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE9802937A SE9802937D0 (sv) 1998-09-01 1998-09-01 Novel compounds
SE9802937 1998-09-01
PCT/SE1999/001469 WO2000012489A1 (en) 1998-09-01 1999-08-27 1, 2, 4-triazole-3-thione compounds

Publications (2)

Publication Number Publication Date
DE69907926D1 true DE69907926D1 (de) 2003-06-18
DE69907926T2 DE69907926T2 (de) 2004-02-19

Family

ID=20412435

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69907926T Expired - Fee Related DE69907926T2 (de) 1998-09-01 1999-08-27 1,2,4-triazol-3-thion verbindungen

Country Status (8)

Country Link
US (1) US20020086862A1 (de)
EP (1) EP1109790B1 (de)
JP (1) JP2002525281A (de)
AT (1) ATE240303T1 (de)
AU (1) AU5892399A (de)
DE (1) DE69907926T2 (de)
SE (1) SE9802937D0 (de)
WO (1) WO2000012489A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2361003A (en) * 2000-04-07 2001-10-10 Astrazeneca Ab Novel compounds
HUP0300754A3 (en) * 2000-07-18 2009-03-02 Smithkline Beecham Corp Use of il-8 receptor antagonists in the treatment of virus infections
WO2004069809A1 (en) 2003-02-03 2004-08-19 Janssen Pharmaceutica N.V. Mercaptoimidazoles as ccr2 receptor antagonists
US7276050B2 (en) * 2004-03-02 2007-10-02 Alan Franklin Trans-scleral drug delivery method and apparatus
CN1933832A (zh) * 2004-03-08 2007-03-21 惠氏公司 离子通道调节剂
CN101001844A (zh) * 2004-08-11 2007-07-18 詹森药业有限公司 作为ccr2受体拮抗剂的巯基咪唑
WO2006103119A2 (en) * 2005-04-01 2006-10-05 Galderma Research & Development Tyrosinase inhibitors, process for the preparation thereof and use thereof in human medicine and also in cosmetics
FR2883875A1 (fr) * 2005-04-01 2006-10-06 Galderma Res & Dev Nouveaux inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
EP2235005A2 (de) * 2007-12-19 2010-10-06 Basf Se Azolylmethyloxirane, ihre verwendung sowie sie enthaltende mittel
CN101945580A (zh) * 2007-12-19 2011-01-12 巴斯夫欧洲公司 唑基甲基环氧乙烷、其应用和包含它们的组合物
US20100311581A1 (en) * 2007-12-19 2010-12-09 Basf Se Azolylmethyloxiranes, use Thereof and Agents Containing the Same
TWI487705B (zh) 2009-12-17 2015-06-11 Lundbeck & Co As H 作為ｐｄｅ１０ａ酵素抑制劑之雜芳香族芳基***衍生物
WO2013134562A1 (en) 2012-03-09 2013-09-12 Inception 2, Inc. Triazolone compounds and uses thereof
WO2014099503A1 (en) 2012-12-20 2014-06-26 Inception 2, Inc. Triazolone compounds and uses thereof
CN103012233B (zh) * 2012-12-26 2015-08-26 华润赛科药业有限责任公司 一种n-(氨基硫代甲基)-5-氧代-1-丙基-2-吡咯烷乙酰胺的制备方法
PE20160880A1 (es) 2013-09-06 2016-09-22 Inception 2 Inc Compuestos de triazolona y usos de los mismos

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW467902B (en) * 1996-07-31 2001-12-11 Bristol Myers Squibb Co Diphenyl heterocycles as potassium channel modulators

Also Published As

Publication number Publication date
SE9802937D0 (sv) 1998-09-01
DE69907926T2 (de) 2004-02-19
ATE240303T1 (de) 2003-05-15
WO2000012489A1 (en) 2000-03-09
JP2002525281A (ja) 2002-08-13
EP1109790A1 (de) 2001-06-27
AU5892399A (en) 2000-03-21
EP1109790B1 (de) 2003-05-14
US20020086862A1 (en) 2002-07-04

Similar Documents

Publication Publication Date Title
DE69905170D1 (en) Thiazolopyrimidinderivate
SE9704546D0 (sv) Novel compounds
TR200100054T2 (tr) Paroksetin metansülfonat
DK0960107T3 (da) 6-Thiosubstituerede paclitaxeler
SE9704544D0 (sv) Novel compounds
PT1036058E (pt) Deribvados de adamantano
TNSN97010A1 (fr) Cyclopentanopyridyl-oxazolidinones contenant des heteroatomes.
ATE240303T1 (de) 1,2,4-triazol-3-thion verbindungen
YU13301A (sh) Muskarinski agonisti i antagonisti
AP1703A (en) Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same.
IL101358A0 (en) Crystalline tiagabine hydrochloride monohydrate,its preparation and pharmaceutical compositions containing it
ATE500269T1 (de) Verbindungen mit wachstumshormon-freisetzenden eigenschaften
AP2001002369A0 (en) Pharmaceutical complex.
WO2002066492A3 (fr) Anticorps specifique de l'adrenomedulline humaine, composition pharmaceutique le contenant, ses applications therapeutiques.
IT1290910B1 (it) 2-amminotetralina otticamente attiva, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono, attive
EP1011329A4 (de) 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele
MXPA04005226A (es) 1,3-diarilprop-2-en-1-onas, composiciones que las contienen y su utilizacion.
ATE272651T1 (de) Verbindungen mit wachstumshormon-freisetzender eigenschaft
ZA981275B (en) Disubstituted bicyclic heterocycles, the preparation and the use thereof as pharmaceutical compositions.
TWI231815B (en) Glycopeptide derivatives and pharmaceutical compositions containing the same for use as antibacterial agents
ZA986139B (en) Sulphonamide compounds, processes for their preparation, pharmaceutical compositions containing the same and their use in therapy.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee